Change Language

Select Language

Global Silver Wound Dressing Market to Reach US$ 1,223.6 Million by 2027, Impelled by Rising Chronic Wounds and Injuries Cases

Published on Sep 13, 2022

IMARC Group’s latest report, titled “Silver Wound Dressing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” finds that the global silver wound dressing market size reached US$ 882.4 Million in 2021. Silver wound dressings are advanced wound care products designed to manage bioburden by releasing steady amounts of silver to the wound to provide antibacterial and antimicrobial action. They are widely used as primary or secondary dressings to prevent infection and promote faster wound healing. These dressings help contain and manage minimal, moderate, or heavy exudates in surgical wounds, pressure ulcers, diabetic foot ulcers, venous leg ulcers, and burns. They can be used under compression or with select topical and adjunctive therapies to minimize the bacterial load and improve the appearance of the wound’s granulation tissue. As a result, silver wound dressings find extensive applications across the healthcare industry in treating acute or chronic wounds.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Global Silver Wound Dressing Market Trends:

The rising chronic wounds and injuries cases and improving healthcare infrastructure represent the primary factors driving the market growth. Moreover, the increasing number of surgeries has augmented the product demand to prevent surgical site infections and promote rapid healing. In addition, there has been a significant shift from traditionally used wound care and closure products toward advanced wound care treatment solutions like silver dressings, as they provide a wide range of antimicrobial activity and alter metalloproteinases within wounds. Along with this, the surging incidences of chronic diseases, such as cancer, diabetes, and cardiovascular diseases (CVDs), are positively influencing the market growth. Furthermore, the leading players are launching novel product variants, such as bioresorbable wound dressing with gallium and silver metal ions, to expand their product portfolio and customer base. In line with this, the widespread availability of silver wound dressings based on the patient and wound needs, such as exudate level, wound depth, odor control, ease of removal, and safety has accelerated the product adoption rate. Other factors, including the increasing road accidents, shifting preferences toward home healthcare, expanding geriatric population, technological advancements, and ongoing product innovations, are also creating a favorable market outlook. Looking forward, IMARC Group expects the market value to reach US$ 1,223.6 Million by 2027, growing at a CAGR of 5.30% during 2022-2027.

Market Summary:

  • Based on the type, the market has been segmented into hydrofiber silver, nanocrystalline silver, silver plated nylon fiber, silver nitrate, silver alginate, and other dressings. 
  • On the basis of the disease, the market has been classified into ulcers, burns, cuts and lacerations, and others. 
  • The market has been bifurcated based on the end user into inpatient and outpatient facilities. 
  • Region-wise, the market has been divided into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.      
  • The competitive landscape of the market has also been analyzed, with some of the key players being 3M Company, Advanced Medical Solutions Group plc, B. Braun Melsungen AG, Cardinal Health Inc., Coloplast A/S, ConvaTec Group plc, Ferris Mfg. Corp., Hollister Incorporated, Integra LifeSciences, Medline Industries LP, Mölnlycke Health Care AB, and Smith & Nephew plc.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800


Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91-120-433-0800 )

Drop us an email at